By the end of the 20-week treatment period, both mdx 4cv +RNR and mdx 4cv + μDys mice showed improvements in survival rates compared to mdx 4cv mice, although this did not reach statistical significance ( Supplemental Figure 1 ).
← all excerpts
Gene Therapy Rescues Cardiac Dysfunction in Duchenne Muscular Dystrophy Mice by Elevating Cardiomyocyte Deoxy-Adenosine Triphosphate.
1
—
—